课题基金 / 基金详情

项目摘要

项目成果

Ji Li的其他基金

相似基金

相关文献

中文摘要
翻译
摘要
英文摘要
Abstract Activated protein C (APC) was first identified as a natural anticoagulant enzyme. Besides its anti- coagulant activity, APC exerts cytoprotective effects such as anti-inflammatory and anti-apoptosis. It has revealed that APC reduces the mortality rate and apoptotic rate during cardiac ischemia and reperfusion. However, the mechanism involved in cardioprotection stimulated by APC is still unclear. The objective of this project is to illustrate the mechanism by which APC mediates cardioprotection against ischemic injury. Our preliminary data demonstrated that the administration of APC reduced myocardial infarction during ischemia and reperfusion. AMP-activated protein kinase (AMPK), a cardioprotective signaling, was activated in APC treated mouse heart. Moreover, ischemia and reperfusion-induced stress-activated protein kinase (SAPK/JNK) signaling was attenuated by APC treatment. We hypothesize that APC protects against myocardial ischemic injury by triggering crucial signaling pathways to modulate substrates metabolism and reducing inflammatory response under ischemic stress. Three specific aims will be addressed to test the hypothesis: 1) determine the modulation of AMP activated protein kinase signaling by APC derivatives during ischemia and reperfusion in the heart; 2) determine the effect of APC derivatives on inflammatory response during ischemia and reperfusion in the heart; 3) determine the mechanisms by which APC modulates glucose transport that reduces ROS responsible inflammatory response in the ischemic heart. APC may decrease the pro-inflammatory factors during cardiac ischemia and reperfusion to reduce heart injury. We also will figure out whether anticoagulant domain of APC is not important for its cardioprotction against ischemia and reperfusion injury, which will provide evidence that recombinant APC without anticoagulant activity can be used for therapy of ischemic heart disease without risk of bleeding.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3389/fcvm.2021.798091
发表时间: 2021
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: [Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P, Wang L]
通讯作者: Wang L
DOI: 10.1016/j.bbrc.2022.11.014
发表时间: 2022-11
期刊: Biochemical and biophysical research communications
影响因子: 3.1
作者: [Tran Ngoc Van Le;L. Zoungrana;Hao Wang;M. Fatmi;Di Ren;Meredith Krause-Hauch;Ji Li]
通讯作者: Tran Ngoc Van Le;L. Zoungrana;Hao Wang;M. Fatmi;Di Ren;Meredith Krause-Hauch;Ji Li
Cardiomyocyte Pdk4 response is associated with metabolic maladaptation in aging.
心肌细胞PDK4反应与衰老中的代谢不良有关。
DOI: 10.1111/acel.13800
发表时间: 2023-04
期刊: Aging cell
影响因子: 7.8
作者: []
通讯作者:
DOI: 10.3389/fcvm.2022.850538
发表时间: 2022
期刊: Frontiers in cardiovascular medicine
影响因子: 3.6
作者: [Murphy J, Le TNV, Fedorova J, Yang Y, Krause-Hauch M, Davitt K, Zoungrana LI, Fatmi MK, Lesnefsky EJ, Li J, Ren D]
通讯作者: Ren D
共 6 条
    A Stress Inducible Protein Sestrin2 in Heart Failure
    A Stress Inducible Protein Sestrin2 in Heart Failure
    A Stress Inducible Protein Sestrin2 in Heart Failure
    Activated Protein C in Acute Injury
    海外基金